XML 29 R20.htm IDEA: XBRL DOCUMENT v3.25.0.1

RESEARCH AND DEVELOPMENT EXPENSES (Tables)

9 Months Ended

Dec. 31, 2024

Research and Development [Abstract]

Schedule of research and development expenses

Schedule of research and development expenses
		December 31,				December 31,
		2024				2023
Three months ended		$	240,199			$	593,401
Nine months ended			883,616				1,875,114

X

- References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of capitalized cost and amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-1

+ Details

Name:	us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration